HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Ming Xu Selected Research

Ya-Ming Xu Research Topics

Disease

8Neoplasms (Cancer)
07/2022 - 02/2014
6Prostatic Neoplasms (Prostate Cancer)
12/2023 - 09/2015
5Melanoma (Melanoma, Malignant)
07/2022 - 01/2017
4Renal Cell Carcinoma (Grawitz Tumor)
12/2021 - 01/2017
4Glioma (Gliomas)
10/2020 - 02/2012
2Pain (Aches)
06/2023 - 01/2019
2Chronic Pain
01/2023 - 01/2019
2Adenocarcinoma
01/2017 - 12/2013
1Postoperative Pain
01/2023
1Paralysis (Palsy)
01/2022
1Infections
01/2022
1COVID-19
01/2022
1Experimental Melanoma
01/2021
1Multiple Myeloma
01/2021
1Breast Neoplasms (Breast Cancer)
10/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020
1Hypersensitivity (Allergy)
01/2019
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Neuralgia (Stump Neuralgia)
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2011
1Adenocarcinoma of Lung
05/2002

Drug/Important Bio-Agent (IBA)

4physachenolide CIBA
07/2022 - 01/2021
3SodiumIBA
06/2023 - 01/2019
3Calcium Channels (Calcium Channel)IBA
06/2023 - 01/2019
3WithanolidesIBA
01/2021 - 01/2017
2Opioid Analgesics (Opioids)IBA
01/2023 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
2Poly I-CIBA
12/2021 - 01/2021
2LigandsIBA
01/2021 - 01/2017
2AndrogensIBA
01/2017 - 09/2015
2withaferin AIBA
02/2012 - 12/2011
1(+)-JQ1 compoundIBA
12/2023
1Androgen Receptors (Androgen Receptor)IBA
12/2023
1TriterpenesIBA
01/2023
1cycloartaneIBA
01/2023
1FurinIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1indoleIBA
01/2022
1Serine Proteases (Serine Protease)IBA
01/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2022
1Protease Inhibitors (Protease Inhibitor)IBA
01/2022
1PolynucleotidesIBA
01/2021
1nigerasperone AIBA
10/2020
1physalin FIBA
01/2019
1Opioid Receptors (Opioid Receptor)IBA
01/2019
1GTP-Binding Proteins (G-Protein)IBA
01/2019
1Potassium Channels (Potassium Channel)IBA
01/2019
1Paclitaxel (Taxol)FDA LinkGeneric
01/2019
1PolyketidesIBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Laminin ReceptorsIBA
02/2014
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
02/2014
1TeaIBA
02/2014
1Mitogen-Activated Protein KinasesIBA
02/2014
1Therapeutic UsesIBA
02/2014
1PolyphenolsIBA
02/2014
1secoemestrin DIBA
12/2013
1Glutathione (Reduced Glutathione)IBA
12/2011
1dasycarpuside AIBA
05/2002

Therapy/Procedure

3Therapeutics
01/2022 - 02/2014
2Immunotherapy
12/2021 - 01/2021
1Complementary Therapies (Alternative Medicine)
01/2023
1Drug Therapy (Chemotherapy)
12/2021
1Ligation
01/2019
1Castration
09/2015
1Chemoprevention
02/2014